Absorbed dose estimates for 131I-labelled monoclonal antibody therapy in patients with intraperitoneal pseudomyxoma

Seven patients with intraperitoneal pseudomyxoma originating from the appendix (4 cases) and from the ovary (3 cases) were treated with radioimmunotherapy. During the therapy, nine infusions of 3.0-4.2 GBq of 131I-labelled B72.3 monoclonal antibody were administered. We developed three-dimensional dose calculation software that can utilize activity maps based on SPET images to calculate the absorbed dose distribution using point source kernels. The dose calculation program was employed to calculate absorbed doses to various organs. The calculated dose distributions enable us to evaluate the variation in dose within the organs, which is normally not available using approaches based on geometric models. The patient-specific absorbed dose calculations were compared with doses based on a model that uses photon S-factors derived from a standard phantom. The compared doses agreed well on average, but in some organs showed large discrepancies.

[1]  P. Sugarbaker.  Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. , 1989, Canadian journal of surgery. Journal canadien de chirurgie.

[2]  P. Nuttall.  Methods of Assessment of Absorbed Dose in Clinical Uses of Radionuclides , 1981 .

[3]  G J Hademenos,et al.  Comparison of four scatter correction methods using Monte Carlo simulated source distributions. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  C S Chui,et al.  Radionuclide photon dose kernels for internal emitter dosimetry. , 1996, Medical physics.

[5]  R. Berkowitz,et al.  Pseudomyxoma Peritonei: A Review of 23 Cases , 1994, Obstetrics and gynecology.

[6]  K. Kairemo,et al.  Radioimmunotherapy of solid cancers: A review. , 1996, Acta oncologica.

[7]  M Ljungberg,et al.  A Monte-Carlo program converting activity distributions to absorbed dose distributions in a radionuclide treatment planning system. , 1996, Acta oncologica.

[8]  E. Mok,et al.  Brachytherapy seed dose distribution calculation employing the fast Fourier transform. , 1986, Medical physics.

[9]  R Mohan,et al.  Treatment planning for internal radionuclide therapy: three-dimensional dosimetry for nonuniformly distributed radionuclides. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  S. Savolainen,et al.  Detection of pseudomyxoma peritonei by radioimmunohistochemistry and radioimmunoscintigraphy. , 1996, Cancer biotherapy & radiopharmaceuticals.

[11]  M. Tenhunen,et al.  The effect of three dimensional activity distribution on the dose planning of radioimmunotherapy for patients with advanced intraperitoneal pseudomyxoma , 1997, Cancer.

[12]  J. Laitinen,et al.  SPECT-based radioimmunotherapy planning system , 1997, Proceedings of the 19th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 'Magnificent Milestones and Emerging Opportunities in Medical Engineering' (Cat. No.97CH36136).

[13]  C. Mulhern,et al.  External imaging techniques for quantitation of distribution of I-131 F(ab')2 fragments of monoclonal antibody in humans. , 1984, Medical physics.

[14]  E E Watson,et al.  A model of the peritoneal cavity for use in internal dosimetry. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  Kenneth F. Koral,et al.  Preliminary results from intensity‐based CT‐SPECT fusion in I‐131 anti‐B1 monoclonal‐antibody therapy of lymphoma , 1997, Cancer.

[16]  J. Siegel,et al.  MIRD formulation. , 1993, Medical physics.

[17]  E. Yorke,et al.  Treatment planning for radio-immunotherapy. , 1996, Physics in medicine and biology.

[18]  R L Wahl,et al.  CT-SPECT fusion plus conjugate views for determining dosimetry in iodine-131-monoclonal antibody therapy of lymphoma patients. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  R Mohan,et al.  Three-dimensional dosimetry for radioimmunotherapy treatment planning. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  C S Chui,et al.  A Monte Carlo approach to patient-specific dosimetry. , 1996, Medical physics.

[21]  Murray H. Loew,et al.  Use of the fast Hartley transform for efficient 3D convolution in calculation of radiation dose , 1994, Proceedings of 16th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[22]  D A Podoloff,et al.  Development of a SPECT-based three-dimensional treatment planning system for radioimmunotherapy. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  J. Schlom,et al.  Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients. , 1995, Anticancer research.

[24]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[25]  D. Podoloff,et al.  Improved conjugate view quantitation of I-131 by subtraction of scatter and septal penetration events with a triple energy window method. , 1995, Medical physics.

[26]  A L Boyer,et al.  Validation of a dose-point kernel convolution technique for internal dosimetry , 1995, Physics in medicine and biology.